Journal Of Clinical Oncology (jco) Podcast

Identifying High-Risk Myeloma

Informações:

Synopsis

FISH genetics, LDH and beta 2-microglobulin can identify a group of newly diagnosed myeloma patients with a two-year survival of only 52% in spite of bortezomib-based therapy.